The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae

Daniel H.F. Rubin; Jonathan D.C. Ross; Yonatan H. Grad

doi:10.1016/j.trsl.2020.02.002

The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae

Daniel H.F. Rubin, Jonathan D.C. Ross, Yonatan H. Grad^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

21 Citations (SciVal)

Original language	English
Pages (from-to)	122-137
Number of pages	16
Journal	Translational Research
Volume	220
DOIs	https://doi.org/10.1016/j.trsl.2020.02.002
Publication status	Published (VoR) - Jun 2020

Funding

YHG was funded by NIH R01 AI132606 and DHFR by NIH T32 GM007753 . JDCR reports research funding from the UK National Institute for Health Research ( HTA 15/110/02 and HTA 17/65/03 ), personal fees from GSK Pharma, Mycovia and Nabriva Therapeutics, ownership of shares in GSK Pharma and AstraZeneca Pharma, membership of the European Sexually Transmitted Infections Guidelines Editorial Board, membership of the NIHR Funding Committee (Health Technology Assessment programme), editor of NIHR Journals Library, and associate editor of Sexually Transmitted Infections journal. DHFR and YHG have no potential conflicts of interest and all of the authors have read the journal's policy on disclosure of potential conflicts of interest. The authors have read the journal's authorship agreement and the manuscript has been reviewed and approved by all named authors.

Access to Document

10.1016/j.trsl.2020.02.002

Cite this

@article{4c332c47e5d44707b35ee8fc265ce078,

title = "The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae",

author = "Rubin, \{Daniel H.F.\} and Ross, \{Jonathan D.C.\} and Grad, \{Yonatan H.\}",

note = "Funding Information: YHG was funded by NIH R01 AI132606 and DHFR by NIH T32 GM007753 . JDCR reports research funding from the UK National Institute for Health Research ( HTA 15/110/02 and HTA 17/65/03 ), personal fees from GSK Pharma, Mycovia and Nabriva Therapeutics, ownership of shares in GSK Pharma and AstraZeneca Pharma, membership of the European Sexually Transmitted Infections Guidelines Editorial Board, membership of the NIHR Funding Committee (Health Technology Assessment programme), editor of NIHR Journals Library, and associate editor of Sexually Transmitted Infections journal. DHFR and YHG have no potential conflicts of interest and all of the authors have read the journal's policy on disclosure of potential conflicts of interest. The authors have read the journal's authorship agreement and the manuscript has been reviewed and approved by all named authors. Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = jun,

doi = "10.1016/j.trsl.2020.02.002",

language = "English",

volume = "220",

pages = "122--137",

journal = "Translational Research",

issn = "1931-5244",

publisher = "Elsevier",

}

TY - JOUR

T1 - The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae

AU - Rubin, Daniel H.F.

AU - Ross, Jonathan D.C.

AU - Grad, Yonatan H.

N1 - Funding Information: YHG was funded by NIH R01 AI132606 and DHFR by NIH T32 GM007753 . JDCR reports research funding from the UK National Institute for Health Research ( HTA 15/110/02 and HTA 17/65/03 ), personal fees from GSK Pharma, Mycovia and Nabriva Therapeutics, ownership of shares in GSK Pharma and AstraZeneca Pharma, membership of the European Sexually Transmitted Infections Guidelines Editorial Board, membership of the NIHR Funding Committee (Health Technology Assessment programme), editor of NIHR Journals Library, and associate editor of Sexually Transmitted Infections journal. DHFR and YHG have no potential conflicts of interest and all of the authors have read the journal's policy on disclosure of potential conflicts of interest. The authors have read the journal's authorship agreement and the manuscript has been reviewed and approved by all named authors. Publisher Copyright: © 2020 Elsevier Inc.

PY - 2020/6

Y1 - 2020/6

UR - https://www.scopus.com/pages/publications/85082527179

UR - https://www.scopus.com/inward/citedby.url?scp=85082527179&partnerID=8YFLogxK

U2 - 10.1016/j.trsl.2020.02.002

DO - 10.1016/j.trsl.2020.02.002

M3 - Review article

C2 - 32119845

AN - SCOPUS:85082527179

SN - 1931-5244

VL - 220

SP - 122

EP - 137

JO - Translational Research

JF - Translational Research

ER -

The frontiers of addressing antibiotic resistance in Neisseria gonorrhoeae

Funding

Access to Document

Other files and links

Fingerprint

Cite this